Hyderabad, Nov 7 (UNI) Balaxi Pharmaceuticals Limited (Balaxi), a branded IPR-based pharmaceutical company on Monday reported a 28.5 per cent increase in the net profit to Rs 15.49 crore for the second quarter ended on September 30, 2022, against Rs 12.05 crore in the corresponding period in the previous year.
The robust revenue growth of 23 per cent Y-o-Y during Q2FY23 period was led by the…
The Central Africana™ reports and aggregates business, socio-economic, Tech and industrial news on Central African countries.
We provide press release distribution to media outlets in Central African countries: Angola, Cameroon, Central African Republic, Chad, Democratic Republic of the Congo, Congo, Equatorial Guinea, Gabon, “Sao Tome and Principe”. To submit a press release today, contact us.
